Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Generics Industry Group Gets New Board Chair, Begins Search For New CEO In Earnest

Dec 09 2023

• By Derrick Gingery

generic drugs — AAM could have a new board chair and CEO in 2024. • Source: Shutterstock

Related Content

AAM CEO Leonard Departs After Two Years, Creating Another Trade Group Searching For New Leader

Dec 06 2022

AAM Departures Lead To Change Of Chair For IGBA

Mar 22 2023

Inflation, Biosimilars, And The Wizard Of Oz: An Interview With Teva’s Christine Baeder

Feb 15 2023

With Video Testimonial Campaign, Generics Industry Aims To Not Be Taken ‘4GRxANTED’

Feb 21 2023

BIO’s New CEO Is Biotech Industry Veteran With Compelling Family Story, Ready To Take On The IRA

Dec 06 2023

Generic Policy Tweaks In Omnibus Legislation Include Processes Improvements On Late-Stage Label Changes, 505(b)(2) TE Designations

Dec 23 2022

A Bad Fit: Dan Leonard’s Leadership Style Did Not Translate At Generics Group

Jan 09 2023

Teva Looks To Novartis To Replace Departing Dethlefs

Sep 29 2023

Related Companies

Sandoz Inc.

Teva Pharmaceutical Industries Ltd.

Novartis AG

Additional Topics

United States Generic Drugs Leadership Politics Regulation Biosimilars Lobbying Policy BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window